SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPod Point Regulatory News (PODP)

  • There is currently no data for PODP

Director Declaration

2 Jun 2025 08:02

RNS Number : 9756K
Pod Point Group Holdings PLC
02 June 2025
 

2 June 2025

 

 

Pod Point Group Holdings plc

(the "Company" or "Pod Point")

 

Director Declaration

 

In accordance with UKLR6.4.9R, Dr Margaret Amos, Non-Executive Director of Pod Point, has notified the Company that she has been appointed as a Non-Executive Director of Oxford Metrics plc ("Oxford") with immediate effect. With effect from 1st July, Margaret will be Head of Oxford's Audit Committee and be appointed as a member of its Remuneration Committee.

 

 

 

Anita Guernari

Company Secretary

 

Enquiries

Teneo(Public relations advisor to Pod Point)

+44 207 353 4200

85fs.podpoint@teneo.com

Mark Burgess, Matt Low, Arthur Rogers

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNFTMRTMTMMMMA
Date   Source Headline
27th Sep 20224:36 pmRNSPrice Monitoring Extension
2nd Sep 20227:00 amRNSExercise of Options and Issue of New Shares
16th Aug 20227:00 amRNSDirector/PDMR Shareholding
28th Jul 20227:00 amRNSHalf-year Report
30th Jun 20227:00 amRNSCFO Designate Appointment
10th Jun 20223:00 pmRNSSecond Manufacturer Contract
8th Jun 20226:30 pmRNSBlock listing Interim Review
27th May 20224:36 pmRNSPrice Monitoring Extension
9th May 20225:45 pmRNSPublication of Annual Financial Report (updated)
9th May 20224:43 pmRNSPublication of Annual Financial Report
4th May 20222:28 pmRNSDirector Declaration
11th Apr 202212:05 pmRNSNew Contract Win
14th Mar 20224:30 pmRNSDirector/PDMR Shareholding
11th Mar 20225:25 pmRNSDirector Declaration
21st Feb 20229:00 amRNSEstablishment of new ESG Committee
18th Feb 20227:00 amRNSPreliminary Unaudited Results for FY2021
6th Jan 20227:00 amRNSTrading Update and Notice of Results
4th Jan 202211:00 amRNSTotal Voting Rights
20th Dec 20215:30 pmRNSDirector Declaration
20th Dec 20214:00 pmRNSAppointment of Joint Corporate Brokers
3rd Dec 20216:33 pmRNSExercise of Over-allotment Option
3rd Dec 20214:57 pmRNSPost-Stabilisation Period Announcement
3rd Dec 20212:15 pmRNSBlock Listing Application
1st Dec 202110:06 amRNSTotal Voting Rights
25th Nov 20214:13 pmRNSNew Contract Win
16th Nov 202111:57 amRNSHolding(s) in Company - Replacement
12th Nov 20217:00 amRNSMid-stabilisation Period Announcement
11th Nov 20214:38 pmRNSHolding(s) in Company
9th Nov 20217:21 amRNSAdmission to Trading on the London Stock Exchange
4th Nov 20211:51 pmRNSApproval and Publication of Prospectus
4th Nov 20217:00 amRNSPre-Stabilisation Period Notice
4th Nov 20217:00 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.